A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose

Kyle D. Holen, Chandra P. Belani, George Wilding, Suresh Ramalingam, Jennifer L. Volkman, Ramesh K. Ramanathan, Lakshmi S. Vasist, Carolyn J. Bowen, Jeffrey P. Hodge, Mohammed M. Dar, Peter T.C. Ho

Research output: Contribution to journal › Article › peer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds